The global nuclear imaging system and equipment market was valued at $2.9 billion in 2023 and is expected to reach $5.6 billion by 2033, growing at a CAGR of 6.8% from 2024 to 2033. Rising demand for accurate diagnostics and technological innovations in imaging are driving market growth.
► Don’t Miss Out “Download Your Exclusive Sample PDF Report” Now:
https://www.alliedmarketresearch.com/request-toc-and-sample/1539
Nuclear imaging uses radioactive tracers to capture images of internal organs, enabling early detection and treatment planning for various diseases. The technique’s ability to provide functional imaging—rather than purely anatomical—makes it vital in oncology, cardiology, and neurology diagnostics.
Rising cases of chronic diseases such as cancer, cardiac and neurological disorders, increasing awareness about the early diagnosis of disease and technological advancements have boosted the growth of the medical imaging systems market.
Key Market Drivers and Limitations
The growing prevalence of chronic diseases, technological advancement in hybrid imaging systems (such as PET-CT and SPECT-CT), and the adoption of AI-assisted image processing are propelling the market forward. The integration of healthcare technology devices and improved tracer chemistry has enhanced diagnostic precision.
Conversely, high equipment costs, radiation safety concerns, and limited availability of isotopes could restrict market growth. Developing nations face additional challenges related to infrastructure and skilled personnel shortages.
Strategies such as product launch and collaborations have been adopted by the companies for market growth. GE Healthcare launched products such as Brivo XR118 (2015) and Brivo XR115 (November 2013) which is high frequency mobile generator to produce images of high quality. Besides, Philips also released its product such as Vereos Digital PET/CT, Ingenuity TF to improve the performance of PET/CT scanners.
The key players of this market include Royal Philips Healthcare, GE Healthcare, Siemens Healthcare, Digirad Corporation, DDD-Diagnostics A/S, Toshiba Medical Systems Corporation, Neusoft Medical Systems Co. Ltd., Mediso Medical Imaging Systems, Ltd., SurgicEye GmbH and CMR Naviscan Corporation.
👉 For Purchase Inquiry of Report:
https://www.alliedmarketresearch.com/purchase-enquiry/1539
Regional and Segment Insights
North America dominates due to advanced medical infrastructure and adoption of cutting-edge imaging systems. Europe remains a significant contributor, while Asia-Pacific is expected to show the fastest growth rate, supported by government healthcare initiatives and expanding diagnostic networks.
By product type, PET scanners hold the major share, followed by SPECT systems and hybrid imaging technologies. Hospitals and imaging centers are the largest end users, with research institutes contributing to innovation.
Overall, the nuclear imaging system market is poised for steady growth through 2033. Continuous technological evolution, rising investment in medical diagnostics, and global healthcare modernization are expected to sustain strong demand across key regions.
About Us –
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact Us:
United States
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Int’l: +1-503-894-6022
Toll Free: +1-800-792-5285
Fax: +1-800-792-5285
[email protected]
